These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 7496445

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A positive pharmacological erection test does not rule out arteriogenic erectile dysfunction.
    Cormio L, Nisén H, Selvaggi FP, Ruutu M.
    J Urol; 1996 Nov; 156(5):1628-30. PubMed ID: 8863555
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Technetium-99m-labelled RBC erection penogram to differentiate psychogenic from vasculogenic impotence.
    Shen YY, Kao CH.
    Urol Int; 1998 Oct; 61(1):27-31. PubMed ID: 9792979
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Initial experiences with prostaglandin E1 and PGE1 prepared injections].
    Mattarelli G, Leibundgut B.
    Helv Chir Acta; 1991 Sep; 58(3):335-7. PubMed ID: 1769856
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of Intracavernosal Injection of Prostaglandin E1 on Duration and Rigidity of Erection in Patients With Vasculogenic Erectile Dysfunction: Is It Dose Dependent?
    Bassiem MA, Ismail IY, Salem TA, El-Sakka AI.
    Urology; 2021 Feb; 148():173-178. PubMed ID: 33017615
    [Abstract] [Full Text] [Related]

  • 11. A pilot study of the role of intracavernous injection of vasoactive intestinal peptide (VIP) and phentolamine mesylate in the treatment of erectile dysfunction.
    McMahon CG.
    Int J Impot Res; 1996 Dec; 8(4):233-6. PubMed ID: 8981173
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intracavernous injection of prostaglandin E1: the application to cavernosography and penile blood flow measurement for the diagnosis of venogenic impotence.
    Ishigooka M, Irisawa C, Watanabe H, Adachi M, Ishii N, Nakada T.
    Urol Int; 1991 Dec; 46(2):193-6. PubMed ID: 2053230
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of sexual impotency by intra-cavernous injections of prostaglandin E1. Report of 180 patients].
    Amar E, Kobelinsky M, Khoury R, Sarkis P, Bouyer I, Dauphin A, Delmas V, Boccon-Gibod L.
    Prog Urol; 1993 Dec; 3(6):971-8. PubMed ID: 8305940
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
    Staerman F, Veilhan LA, Guiraud P, Coeurdacier P, Cipolla B, Lobel B.
    Prog Urol; 1996 Dec; 6(4):564-8. PubMed ID: 8924934
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.